Delivery Order SPE2DB22D3011-SPE2DB24FP9VW
Award Date 3/14/24
Potential Completion Date 3/15/24
Potential Value $1.2K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This $8,987.05 firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the Amerisourcebergen Corporation, to provide 4,564,205,713 units of Ondansetron ODT 4 mg tablets. The award is part of an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that enables Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA Troop Support Medical facilities...
- This is a firm fixed price delivery order for $13,846.57 awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The order is for the supply of 4,564,205,429 units of the pharmaceutical product Ondansetron ODT 4 mg tablet in 30-count packages. The delivery order has an ultimate completion date of April 9, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract with DLA valued up to $999,999,999.00 through...
- This is a $8,769.42 firm fixed price delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for the supply of 4,564,233,461 units of the pharmaceutical product Ondansetron ODT 4 mg tablets. This delivery order was awarded under an indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp, which has a potential total value of $999,999,999.00 and a performance...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The $5,373.53 award is for the supply of 4,563,943,906 units of Ondansetron ODT 8 mg tablets. AmerisourceBergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to provide pharmaceutical...
- This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,567,957,266 units of the medication Ondansetron ODT 4 mg tablet. The order has a ceiling value of $5,173.92 and an ultimate completion date of April 18, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support...
- This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,182.54 contract is for the delivery of Ondansetron ODT 8 mg tablets. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to $999,999,999 and running through November 2026. This IDC allows the DLA to...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $1,168.60 order is for the supply of ondansetron ODT 4 mg tablets to support military treatment programs and facilities. The delivery order was issued under an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded solely...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Amerisourceberen Corporation, a leading global pharmaceutical distribution company. The $6,903.46 delivery order is for the supply of 4,564,260,931 units of the pharmaceutical product ondansetron ODT 8 mg tablets. The delivery order was issued under an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4,565,282,803 units of the prescription medication Ondansetron ODT 4 mg Tablet (30s). The contract has a ceiling value of $7,703.86 and is a firm fixed price delivery order with a period of performance through July 30, 2024. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor for this award, which is not designated as a set-aside contract....
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, Corporate Office Division. The contract, valued at $13,022.94, is for the supply of 4,566,043,705 units of Ondansetron ODT 8 mg Tablets in 30-count packages. This award does not have a set-aside designation. The delivery order falls under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December...
- SPE2DB22D3011Indefinite Delivery Contract
- SPE2DB22D3011-SPE2DB24FP9VWDelivery Order
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The $1,222.90 delivery order is for the supply of 4,563,969,438 units of Ondansetron ODT 8 mg tablets. This delivery order falls under a larger indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp with a potential value of $999,999,999.00, which serves as the primary contract vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The contract does not have a set-aside designation.
Generated 6/13/24, 9:36 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 3/14/24 |